Parag H. Joshi

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

Friedewald-Estimated Versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications

Seth S. Martin, Michael J. Blaha, Mohamed B. Elshazly et al. · Journal of the American College of Cardiology · 2013 · 411 citations

Cardiovascular Disease, Biostatistics, Dyslipidemia +5

Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study

Hisham Dokainish, Koon Teo, Jun Zhu et al. · The Lancet Global Health · 2017 · 385 citations · Full text

Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial

Ian J. Neeland, Steven P. Marso, Colby Ayers et al. · The Lancet Diabetes & Endocrinology · 2021 · 174 citations

Obesity, Metabolic Syndrome, Cardiovascular Disease +7

Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies

Parag H. Joshi, Arif Khokhar, Joseph M. Massaro et al. · Journal of the American Heart Association · 2016 · 171 citations · Full text